Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anticoagulant therapy for DVT after endovenous RFCA
ChiCTR-IPR-17010898Phase 4Recruiting
- Sponsor
- The First People's Hospital of Yunnan Province
- Start
- Mar 2017
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of heparin in Phlebothrombosis (2 arms), sponsored by The First People's Hospital of Yunnan Province. Primary endpoint: Venous thrombosis. Started Mar 2017; status: recruiting.
02
Drugs
heparin
03
Conditions
Phlebothrombosis
Beyond the preview
Go deeper on ChiCTR-IPR-17010898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010898.